A Revolutionary Gene Therapy Offers Hope for Non-Addictive Chronic Pain Relief

A groundbreaking preclinical study has unveiled a novel gene therapy that directly targets the brain’s pain-processing pathways, presenting a significant potential alternative to opioid painkillers and their associated addiction risks.…

Medicines Regulator Investigates UK Clinics for Unsubstantiated Peptide Therapy Claims

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched an investigation into UK clinics that are reportedly making medicinal claims for peptide treatments, raising concerns about the legality and…

A Groundbreaking Gene Therapy Offers Hope for Non-Addictive Pain Relief, Targeting Brain Circuits Without Opioid Risks

A pioneering preclinical study has unveiled a novel gene therapy designed to directly target the brain’s pain-processing areas, offering a potential paradigm shift in the management of chronic pain and…